Dianthus Therapeutics, Inc. (DNTH)

105.84 -5.11% (-5.70)

Over 1M: -1.0%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

105 110 115
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Cash Flow: -14.1M Q3 '21 — Free Cash Flow: -15.2M Q3 '21 — Net Income: -17.4M Q4 '21 — Operating Cash Flow: -15.7M Q4 '21 — Free Cash Flow: -15.7M Q4 '21 — Net Income: -19.3M Q1 '22 — Operating Cash Flow: -19.7M Q1 '22 — Free Cash Flow: -19.8M Q1 '22 — Net Income: -4.9M Q2 '22 — Operating Cash Flow: -16.9M Q2 '22 — Free Cash Flow: -17M Q2 '22 — Net Income: -5.7M Q3 '22 — Revenue: 1.2M Q3 '22 — Operating Cash Flow: 16.4M Q3 '22 — Free Cash Flow: 16.2M Q3 '22 — Net Income: -7.8M Q4 '22 — Revenue: 1.2M Q4 '22 — Operating Cash Flow: -8.9M Q4 '22 — Free Cash Flow: -8.9M Q4 '22 — Net Income: -10.1M Q1 '23 — Operating Cash Flow: -10.3M Q1 '23 — Free Cash Flow: -10.5M Q1 '23 — Net Income: -7.1M Q2 '23 — Operating Cash Flow: -4.7M Q2 '23 — Free Cash Flow: -4.7M Q2 '23 — Net Income: -11.1M Q3 '23 — Revenue: 924K Q3 '23 — Operating Cash Flow: -10M Q3 '23 — Net Income: -14.8M Q4 '23 — Revenue: 457K Q4 '23 — Operating Cash Flow: -11.9M Q4 '23 — Net Income: -10.6M Q1 '24 — Revenue: 874K Q1 '24 — Operating Cash Flow: -14.9M Q1 '24 — Net Income: -13.7M Q2 '24 — Revenue: 1.9M Q2 '24 — Operating Cash Flow: -14.5M Q2 '24 — Net Income: -17.6M Q3 '24 — Revenue: 2.2M Q3 '24 — Operating Cash Flow: -21.3M Q3 '24 — Net Income: -25.2M Q4 '24 — Revenue: 1.3M Q4 '24 — Operating Cash Flow: -27.4M Q4 '24 — Net Income: -28.4M Q1 '25 — Revenue: 1.2M Q1 '25 — Operating Cash Flow: -27.6M Q1 '25 — Net Income: -29.5M Q2 '25 — Revenue: 193K Q2 '25 — Operating Cash Flow: -23.9M Q2 '25 — Net Income: -31.6M Q3 '25 — Revenue: 396K Q3 '25 — Operating Cash Flow: -30.6M Q3 '25 — Net Income: -36.8M Q4 '25 — Revenue: 284K Q4 '25 — Operating Cash Flow: -47M Q4 '25 — Net Income: -64.4M Q1 '26 — Operating Cash Flow: -28.9M Q1 '26 — Net Income: -40.8M Q2 '26 — Operating Cash Flow: -49M Q2 '26 — Net Income: -50.2M -60M -40M -20M 0 20M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.5
ROIC -60.3%
Accruals -3.0%
Asset turnover 0.0017×
ROA -15.8%
ROCE -18.5%
ROE -16.4%
Capex / sales —
EBITDA margin —
FCF margin —
Gross margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
SBC / sales —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 0.75×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

8.7
Current ratio 27.3×
ND/EBITDA —
Cash runway 5.7 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 26.1×
F-score 1.3 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.4
Sales/sh Y/Y -71.8%
Sales Q/Q -78.6%
Shares change +15.9%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.